ArticleScientific reports2026
Microbial synthesis of silver nanoparticles using bacterial supernatants from Brazilian stingless bees with antimicrobial activity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular and Intracellular Bacterial Compounds in the Synthesis of Inorganic Particles: Silver Nanoparticles.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
The increasing prevalence of antibiotic-resistant bacteria poses a significant global public health challenge, particularly with multidrug-resistant pathogens such as Staphylococcus aureus and Escherichia coli. In this context, silver nanoparticles (AgNPs) have garnered attention as promising alternative antimicrobial materials due to their unique physicochemical properties. In this study, we investigated the green synthesis of AgNPs using bacterial supernatants derived from the larval food of Brazilian stingless bees, a biologically rich and underexplored source of functional metabolites. Using supernatants of Providencia rettgeri and Proteus mirabilis, AgNPs were synthesized via both traditional and microwave-assisted methods, with the latter promoting faster nanoparticle formation and improved colloidal homogeneity. Two AgNP formulations (AgNPs-1B and AgNPs-54B), selected for their distinct synthesis profiles, were characterized by UV-visible spectroscopy, dynamic light scattering, scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and transmission electron microscopy (TEM). TEM analysis revealed predominantly spherical nanoparticles, with average diameters of 24.2 ± 27.4 nm for AgNPs-1B and 8.5-25.2 nm for AgNPs-54B, confirming successful nanoscale synthesis. Both AgNPs exhibited significant antimicrobial activity against multidrug-resistant E. coli and S. aureus. When incorporated into alginate-based membranes, the nanoparticles retained their antimicrobial efficacy, particularly through contact-dependent inhibition of bacterial growth. Toxicity assays using Drosophila melanogaster and human neuron cultures indicated low toxicity in the evaluated biological models. These findings demonstrate the potential of biologically synthesized AgNPs as sustainable antimicrobial materials, combining a unique microbial source with microwave-assisted processing and relevant biomedical and environmental applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.